Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy

OBJECTIVES: A diverse intratumoral T‐cell receptor (TCR) repertoire is associated with improved survival in diffuse large B‐cell lymphoma (DLBCL) treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy. We explored the impact of intratumoral TCR reper...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanavas, Mohamed, Law, Soi‐Cheng, Hertzberg, Mark, Hicks, Rodney J, Seymour, John F, Li, Zhixiu, Merida de Long, Lilia, Nath, Karthik, Sabdia, Muhammed B, Gunawardana, Jay, Gandhi, Maher K, Keane, Colm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548874/
https://www.ncbi.nlm.nih.gov/pubmed/34745610
http://dx.doi.org/10.1002/cti2.1351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548874/
https://www.ncbi.nlm.nih.gov/pubmed/34745610
http://dx.doi.org/10.1002/cti2.1351

Ejemplares similares